PDF herunterladen
Thromb Haemost 1961; 6(01): 063-072
DOI: 10.1055/s-0038-1654540
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Anticoagulant Circulant Ressemblant à l’Antithrombine VI au cours d’un Lupus Érythémateux Disséminé

H Zywicka
1   (Laboratoire de Biochimie clinique et Service des Maladies internes. Institut d’Hématologie Varsovie, Pologne)
,
M Kopeć
1   (Laboratoire de Biochimie clinique et Service des Maladies internes. Institut d’Hématologie Varsovie, Pologne)
,
Z Latallo
1   (Laboratoire de Biochimie clinique et Service des Maladies internes. Institut d’Hématologie Varsovie, Pologne)
,
E Kowalski
1   (Laboratoire de Biochimie clinique et Service des Maladies internes. Institut d’Hématologie Varsovie, Pologne)
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. August 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Résumé

Nous avons décrit le cas d’une malade atteinte de diathèse hémorragique au cours d’un lupus érythémateux.

L’étude de la coagulation sanguine dans ce cas a indiqué aucune anomalie, mis a part une thrombocytopénie modérée, une augmentation de l’activité fibrinolytique et un allongement du temps de thrombine.

Nous avons demontré la présence d’un inhibiteur de la thrombine ressemblant à l’antithrombine VI, antithrombine produite au cours de la dégradation protéolytique du fibrinogène.

Nous avons comparé cette antithrombine avec les autres inhibiteurs de la coagulation apparissants au cours de LE et décrits dans la littérature. L’influence du traitement par les hormones surrénales sur la fibrinolyse et sur disparition de l’antithrombine VI est discutée.

 

  • Bibliographie

  • (1) Bar-Pratkowska J, Niewiarowska M. O aktywnosci fibrynolizy w przypadku przedwczesnego odklejenia iozyska. Pol. Tyg. lek. 13: 1908 1958;
    PubMedSuche in Google Scholar
  • (2) Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path. 6: 23 1953;
    CrossrefPubMedSuche in Google Scholar
  • (3) Bonnin J. A, Cohen A. K, Hicks N. D. Coagulation defects in a case of systematic lupus erythematosus with thrombocytopenia. Brit. J. Haemat. 2: 168 1956;
    CrossrefPubMedSuche in Google Scholar
  • (4) Conley C. L, Hartmann R. C. A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J. clin. Invest. 31: 621 1952;
    PubMedSuche in Google Scholar
  • (5) Cottier P, Leupold R, Schellin W. Die hämorrhagische Diathese des Prostatakarzinoms und ihre Behandlung. Schweiz. med. Wschr. 85: 781 1955;
    PubMedSuche in Google Scholar
  • (6) Crosby W. H, Stefanini M. Pathogenesis of the plasma transfusion reaction with special reference to the blood coagulation system. J. Lab. clin. Med. 40: 374 1952;
    PubMedSuche in Google Scholar
  • (7) Dubois E. L. The effect of the LE cell test on the clinical picture of systemic lupus erythematosus. Ann. intern. Med. 38: 1265 1953;
    CrossrefPubMedSuche in Google Scholar
  • (8) Duckert F, Flückiger P, Isenschmied H, Matter M, Vogel-Meng J, Koller F. A modification of the thromboplastin generation test. Acta haemat. (Basel) 12: 197 1954;
    CrossrefPubMedSuche in Google Scholar
  • (9) Duke W. W. The relationship of blood platelets to haemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of three cases of haemorrhagic disease relived by transfusion. J. Amer. med. Ass. 55: 1185 1910;
    CrossrefPubMedSuche in Google Scholar
  • (10) Fletcher A. P, Alkjaersig N. The maintenance of sustained thrombolytic state in man. J. clin. Invest. 38: 1096 1959;
    CrossrefPubMedSuche in Google Scholar
  • (11) Frick P. G. Acquired circulating anticoagulants in systemic “collagen disease”. Blood 10: 691 1955;
    CrossrefPubMedSuche in Google Scholar
  • (12) Grabar P, Williams C. Méthode immuno-électrophorétique d’analyse de mélanges de substances antigéniques. Biochim. biophys. Acta 27: 67 1955;
    PubMedSuche in Google Scholar
  • (13) Hargraves M. M. The LE cell phenomenon. Proc. Mayo Clin. 27: 419 1952;
    PubMedSuche in Google Scholar
  • (14) Harvey A. M, Shulman L. E, Tumulty P. A, Conley C. L, Schoenrich E. H. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33: 291 1954;
    CrossrefPubMedSuche in Google Scholar
  • (15) Innerfield L, Goldbloom A. A, Boyd L. J. Plasma antithrombin elevation in buccal varidase treated patients. Surgery 43: 956 1958;
    PubMedSuche in Google Scholar
  • (16) Kaulla K. N, Swan H, Kaulla E. Beobachtungen von Gerinnung und Fibrinolyse während chirurgischer Eingriffe am menschlichen Herzen in Unterkühlung oder mittels extrakorporalen Kreislaufes. Klin. Wschr. 36: 1050 1958;
    CrossrefPubMedSuche in Google Scholar
  • (17) Koller F, Loeliger A, Duckert F. Experiments on a new clotting factor (Factor VII). Acta haemat. (Basel) 6: 1 1951;
    CrossrefPubMedSuche in Google Scholar
  • (18) Kopec M, Niewiarowski S. Czynnosc fibrinolityczna osocza osób zdrowych. Pol. Arch. Med. Wewnet. 26: 1322 1956;
    PubMedSuche in Google Scholar
  • (20) Kowarzyk H, Buluk K. Postçpy. Hig. Med. dosw. 2: 1 1950;
    PubMedSuche in Google Scholar
  • (21) Kwaan H. C, McFadzean A. J. S. The inhibition of clot lysis by corticotropin. Lancet I: 136 1956;
    PubMedSuche in Google Scholar
  • (22) Lee S. L, Sauders M. Laboratory studies in systemic lupus erythematosus. Arch. Dermat. Syph. (Chicago) 73: 313 1956;
    PubMedSuche in Google Scholar
  • (23) Lee S. L, Sanders M, Kahny H. M. A disorder of blood coagulation in systemic lupus erythematosus. J. clin. Invest. 34: 1814 1955;
    CrossrefPubMedSuche in Google Scholar
  • (24) Lee R. J, White P. D. A clinical study of the coagulation time of blood. Amer. J. med. Sei. 145: 495 1913;
    CrossrefPubMedSuche in Google Scholar
  • (25) Loeliger A. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?. Thromb. Diath. haem. 3: 237 1959;
    PubMedSuche in Google Scholar
  • (26) Loeliger A, Hers J. F. Chronic antithrombinaemia (antithrombin V) with haemorrhagic diathesis in case of rheumatoid arthritis with hypergammaglobulinaemia. Thromb. Diath. haem. 1: 499 1957;
    PubMedSuche in Google Scholar
  • (27) Meacham G. C, Weisgerber A. S. Unusual manifestations of disseminated lupus erythematosus. Ann. intern. Med. 43: 143 1956;
    PubMedSuche in Google Scholar
  • (28) Michael S. R, Vural I. L, Bassen F. A, Schaefer L. The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood 6: 1059 1951;
    PubMedSuche in Google Scholar
  • (29) Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Rev. Hémat. 13: 320 1958;
    PubMedSuche in Google Scholar
  • (30) Niewiarowski S, Kowalski E, Stachurska J. Influence of fibrinogen derived antithrombin (antithrombin VI) on the blood coagulation system. Acta biochim pol. 6: 43 1959;
    PubMedSuche in Google Scholar
  • (31) Quick A. J. Hemorrhagic diseases. Philadelphia: 1957
    Suche in Google Scholar
  • (32) Ramot C, Singer K. An unusual circulating anticoagulant m systemic lupus erythematosus. Acta haemat. (Basel) 16: 158 1956;
    CrossrefPubMedSuche in Google Scholar
  • (33) Sanchez Medal L, Liskier R. Circulating anticoagulants in disseminated lupus erythematosus. Brit. J. Haemat. 5: 284 1959;
    CrossrefPubMedSuche in Google Scholar
  • (34) Santa R. D, Verniory R, Rousso C, Vienet M, Merminod A. Présence d’un anticoagulant dans le sang d’une malade atteinte, de lupus erythémateux. Schweiz. med. Wschr. 40: 1031 1959;
    PubMedSuche in Google Scholar
  • (35) Sharp A. A, Howe B, Biggs R. Defibrination syndrome in pregnancy. Lancet II: 1309 1958;
    PubMedSuche in Google Scholar
  • (36) Soulier T. P. Les inhibiteurs naturels de la coagulation. Sang 30: 262 1959;
    PubMedSuche in Google Scholar
  • (37) Soulier J. P, Larrieu M. J. Nouvelle méthode de diagnostic de l’hémophilie: dosage de facteurs antihémophiliques A et B. Sang 24: 205 1953;
    PubMedSuche in Google Scholar
  • (38) Swift S. A serum anticoagulant factor in systemic lupus erythematosus. Arch. Dermat. Syph. (Chicago) 74: 296 1956;
    PubMedSuche in Google Scholar
  • (39) Ungar G. Thrombosis and stress. Role of fibrinolytic system. 421 Intern. Conferenc on Thrombosis and Embolism; Basel: 1954
    Suche in Google Scholar
  • (40) Wolf P. A modification for routine laboratory use of Stefanini s method lor estimation of Factor V in human oxalated plasma. J. clin. Path. 6: 34 1953;
    CrossrefPubMedSuche in Google Scholar
  • (41) Zimmer F. E, Hargraves M. M. The effect of blood coagulation on the LE cell formation. Proc. Mayo Clin. 27: 424 1952;
    PubMedSuche in Google Scholar